Forte Biosciences, Inc.

Direct answer

Forte Biosciences, Inc. is publicly traded on NASDAQ under the ticker FBRX.

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.

Can you invest in Forte Biosciences, Inc.?

Yes. Forte Biosciences, Inc. trades publicly on NASDAQ as FBRX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Forte Biosciences, Inc.

Detailed equity research is provided by MarketSnap.